Showing 25 of 71 items meeting your criteria.
| Type | Category | Supplier | |
---|
|
| Product list of Bioreagents for FDA-Approved Therapeutic Mabs and Anti-Drug Mabs |
Documents | ELISA | Abnova Corporation | |
| Abnova Bioactive Proteins Product Lists |
Documents | Proteins | Abnova Corporation | |
| A selection of Abnovas Best-in-Class Bioreagents |
Documents | Catalogue | Abnova Corporation | |
| Abnova provides a range of Autophagy antibodies. |
Documents | Autophagy | Abnova Corporation | |
| HER2, EGFR, HER3, and IGF-1R dimerized with the HER2 receptor induce activation of PI3K/AKT and MAPK/MEK signalling pathways and receive signals to regulate the downstream cascade that promotes the active transcription of genes involved in proliferation, angiogenesis, cell survival, and metastasis. |
Documents | Transcription Factors | Abnova Corporation | |
| Abnova provides a range of Apoptosis biomarkers. |
Documents | Apoptosis | Abnova Corporation | |
| Abnova Corporation provides Antibodies & Proteins Specific for Coronaviruses |
Documents | COVID-19 | Abnova Corporation | |
| Abnova Corporation provides a range of Acute Myeloid Leukemia Antibodies. |
Documents | Cancer | Abnova Corporation | |
| Abnova offers Antibody Drug ELISA Kits. |
Documents | ELISA | Abnova Corporation | |
| Abnova provides Cell Therapy GMP Grade Proteins |
Documents | Recombinant Proteins | Abnova Corporation | |
| Integration is the solution to deciphering the complexity of biology. The core of Abnovas integration is the generation and availability of antibodies and proteins targeting the human genome. These invaluable bio-tools are combined and utilised in a comprehensive repertoire of qualitative, quantitative, multiplexing, high throughput, and profiling applications to address the needs of research and discovery. Abnova has successfully developed and implemented these integrated solutions for the research community and industry. |
Documents | Service | Abnova Corporation | |
| Abnova offers high quality, efficient and cost-saving conjugation services, bridging protein and fluorescent dyes, phycobiliproteins, streptavidin, biotin and enzymes. Since every protein has its own unique characteristics, conjugation needs to be optimised. 0.2mg of total protein of interest will be tested and analysed prior to mass labelling. The tested sample will be mixed with mass conjugate product for final purification. |
Documents | Service | Abnova Corporation | |
| Abnova offers high quality, efficient and cost-saving conjugation services, bridging antibody and fluorescent dyes, phycobiliproteins, streptavidin, biotin and enzymes. Since every antibody has its own unique characteristics, conjugation needs to be optimised. 0.2mg of total antibody of interest will be tested and analysed prior to mass labelling. The tested sample will be mixed with mass conjugate product for final purification. |
Documents | Service | Abnova Corporation | |
| Abnova offers custom IVT mRNA services. 1. mRNA synthesis 2. mRNA Nanoparticle Carrier Mixing 3. nMRNA Nanoparticle Carrier Characterisation 4. mRNA Nanoparticle Carrier In Vitro & In Vivo Studies |
Documents | Service | Abnova Corporation | |
| Abnovas Human CD3/CD28 ActiveBeads™ with humanized antibodies are suitable for immunodeficient xenograft tumour models. In contrast, Mouse CD3/CD28 ActiveBeads™ with anti-mouse antibodies are ideal for immunocompetent syngeneic tumour models to simulate the tumour microenvironment. |
Documents | Beads | Abnova Corporation | |
| Camelid Single Domain Antibodies (sdAbs), also known as nanobodies, have emerged as powerful tools in immunology and molecular biology. CD8A, a vital cell surface glycoprotein in immune responses, has become a focus of research and diagnostics. Derived from camelids, these sdAbs offer advantages such as a small size for precise targeting, stability in extreme conditions, and unique binding capabilities. |
Documents | Antibodies | Abnova Corporation | |
| Abnova offers Camelid Single Domain Antibody Service for production of target-specific sdAb from naïve camelid VHH library. By using the advanced naïve camelid VHH library screening technology, they screen the library and isolate the sdAb clones for your required antigens. Positive clones are sequenced and validated by ELISA. The selected clones will then be introduced into HEK293 expression vector or E. coli expression vector for transient and scalable sdAb production for many downstream applications. |
Documents | Service | Abnova Corporation | |
| Abnova camelid single domain antibodies (sdAbs) derived from alpacas or llamas with great penetrability and affinity to recognize difficult epitopes. The product lines include FluoTag-Q, FluoTag-X2 and FluoTag-X4, featuring different number of sdAb and coupled fluorophore. In FluoTag-Q series, each fluorophore is conjugated to exactly one sdAb. The FluoTag-X2 series contains two fluorophores coupled with one sdAb. In terms of FluoTag-X4, it is a mix of 2 sdAbs that can bind simultaneously with the target molecule, and each sdAb is coupled with 2 fluorophores. |
Documents | Antibodies | Abnova Corporation | |
| Abnova provide a range of PEG and Anti-PEG ELISA Kits. |
Documents | ELISA | Abnova Corporation | |
| Circular RNA sponge, also known as circRNA sponge, is a synthetic RNA molecule derived from in vitro transcription (IVT) and circularization by permutated intron exon (PIE) or enzymatic ligation. circRNA sponge acts as a competitive inhibitor of specific miRNA. It contains multiple binding sites (MREs) for sequestering and "sponging" miRNA, thus preventing miRNA interaction with endogenous target mRNA. Compared to linear RNAs, circRNA sponges lack 5 cap and 3 poly(a) tail and are more resistant to exonucleolytic degradation resulting in higher intracellular levels for miRNA target derepression. circRNA sponges overcomes the toxicity exhibited by anti-miRNA oligonucleotides (AMO) and dosage constraint by the plasmid-based miRNA sponge. circRNA sponges does not require nucleoside modifications and are inherently non-immunogenic. A multitude of circRNA sponge reagents is coming soon. |
Documents | miRNA | Abnova Corporation | |
| Abnovas Research Grade Biosimilars are reliable, cost-effective alternatives for scientific advancement. With comparable efficacy and safety profiles, Abnovas Biosimilars open new research possibilities for assays, cell culture, and preclinical research. |
Documents | Antibodies (Biosimilars) | Abnova Corporation | |
| Abnova RNA In Vitro Transcription Tools Product Lists |
Documents | RNA | Abnova Corporation | |
| Abnova Cytokine ELISA Kits Product Lists |
Documents | ELISA | Abnova Corporation | |
| Abnova Affordable Recombinant Proteins Product Lists |
Documents | Proteins | Abnova Corporation | |
| Pattern recognition receptors (PRRs) are crucial for detecting invading pathogens and initiating the innate and adaptive immune response. There are various families of PRRs including the Toll-like receptors (TLRs), C-type lectin receptors (CLRs), NOD-like receptors (NLRs), RIG-I like receptors (RLRs), and AIM2-like receptors (ALRs). Abnova provide 142 Antibodies, 55 Proteins, and 9 ELISA Kits targeting pattern recognition receptors. |
Documents | Immunology | Abnova Corporation | |